Skip to contentE
Eledon Pharmaceuticals, Inc.
E
ELDNEledon Pharmaceuticals, Inc. ELDN Q3 2020 · Eledon Pharmaceuticals, Inc. · ThalerReleased Nov 16, 2020, after the close
10-Q filed Nov 16, 2020, 47 days after period end · 0001564590-20-054210
Q3 2020 · 10-Q
Revenue—
Net Income-$6.14M-$6.14MN/M vs Q3 2019N/M vs Q2 2020 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
-$5.51-$5.51N/M vs Q3 2019N/M vs Q2 2020 Operating Income-$6,148,000N/M Operating Cash Flowderived-$561,000N/M Filing lag
ended Sep 30, 2020 · filed Nov 16, 2020 · 47 d after period end